As of 2025-07-15, the EV/EBITDA ratio of Ionis Pharmaceuticals Inc (IONS) is -11.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IONS's latest enterprise value is 5,877.98 mil USD. IONS's TTM EBITDA according to its financial statements is -520.46 mil USD. Dividing these 2 quantities gives us the above IONS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 10.7x | 9.4x |
| Forward P/E multiples | 7.2x - 11.2x | 9.2x |
| Fair Price | (21.00) - (29.44) | (24.79) |
| Upside | -149.4% - -169.2% | -158.3% |
| Date | EV/EBITDA |
| 2025-07-11 | -11.07 |
| 2025-07-10 | -11.24 |
| 2025-07-09 | -11.38 |
| 2025-07-08 | -10.92 |
| 2025-07-07 | -11.06 |
| 2025-07-03 | -11.43 |
| 2025-07-02 | -11.61 |
| 2025-07-01 | -10.50 |
| 2025-06-30 | -10.36 |
| 2025-06-27 | -10.45 |
| 2025-06-26 | -10.45 |
| 2025-06-25 | -10.51 |
| 2025-06-24 | -10.40 |
| 2025-06-23 | -9.80 |
| 2025-06-20 | -9.72 |
| 2025-06-18 | -9.60 |
| 2025-06-17 | -9.34 |
| 2025-06-16 | -9.06 |
| 2025-06-13 | -9.17 |
| 2025-06-12 | -9.17 |
| 2025-06-11 | -9.35 |
| 2025-06-10 | -9.55 |
| 2025-06-09 | -9.52 |
| 2025-06-06 | -9.07 |
| 2025-06-05 | -9.06 |
| 2025-06-04 | -9.02 |
| 2025-06-03 | -8.91 |
| 2025-06-02 | -8.71 |
| 2025-05-30 | -8.53 |
| 2025-05-29 | -8.51 |
| 2025-05-28 | -8.20 |
| 2025-05-27 | -8.47 |
| 2025-05-23 | -8.37 |
| 2025-05-22 | -8.45 |
| 2025-05-21 | -8.53 |
| 2025-05-20 | -8.82 |
| 2025-05-19 | -8.69 |
| 2025-05-16 | -8.54 |
| 2025-05-15 | -8.37 |
| 2025-05-14 | -8.25 |
| 2025-05-13 | -8.23 |
| 2025-05-12 | -8.54 |
| 2025-05-09 | -8.15 |
| 2025-05-08 | -8.30 |
| 2025-05-07 | -8.39 |
| 2025-05-06 | -8.02 |
| 2025-05-05 | -8.57 |
| 2025-05-02 | -8.31 |
| 2025-05-01 | -7.98 |
| 2025-04-30 | -7.67 |